| 000 | 00822nam a22002655 4500 | ||
|---|---|---|---|
| 001 | 178971 | ||
| 003 | ES-MaBCM | ||
| 005 | 20241016192412.0 | ||
| 008 | 100709s2010 usa eng d | ||
| 020 | _a978-0-691-14180-0 | ||
| 021 | _axx | ||
| 035 | _a(OCoLC)935723080 | ||
| 040 | _cES-MaBCM | ||
| 100 | 1 |
_aCarpenter, Daniel P. _98376 |
|
| 245 | 0 | 0 |
_aReputation and power _b: organizational image and pharmaceutical regulation at the FDA _cDaniel Carpenter |
| 260 |
_aPrinceton : _bPrinceton University Press, _c2010 |
||
| 300 |
_a802 p. _c24 cm |
||
| 650 | 7 |
_aMedicamento _959374 |
|
| 650 | 7 |
_aEstupefaciente _958443 |
|
| 650 | 7 |
_aPolítica sanitaria _959844 |
|
| 650 | 2 | 7 |
_aPoder ejecutivo _959799 |
| 651 | 2 | 4 |
_aEstados Unidos _9115376 |
| 650 | 7 |
_aEstablecimiento farmacéutico _958688 |
|
| 942 | _cBK | ||
| 999 |
_c178971 _d178971 |
||